Histone deacetylases as targets for treatment of multiple diseases.
Histone deacetylases as targets for treatment of multiple diseases.
复制标题
DOI：
10.1042/cs20120504
复制
发表时间：
2013-06
期刊：
影响因子：
--
通讯作者：
Zhuang S
中科院分区：
文献类型：
--
作者：
Tang J;Yan H;Zhuang S
HDACs (histone deacetylases) are a group of enzymes that deacetylate histones as well as non-histone proteins. They are known as modulators of gene transcription and are associated with proliferation and differentiation of a variety of cell types and the pathogenesis of some diseases. Recently, HDACs have come to be considered crucial targets in various diseases, including cancer, interstitial fibrosis, autoimmune and inflammatory diseases, and metabolic disorders. Pharmacological inhibitors of HDACs have been used or tested to treat those diseases. In the present review, we will examine the application of HDAC inhibitors in a variety of diseases with the focus on their effects of anti-cancer, fibrosis, anti-inflammatory, immunomodulatory activity and regulating metabolic disorders.
